Poultry Vaccines Market Size – Global Industry Analysis, Market Size, Opportunities and Forecast 2021 – 2028

The global poultry vaccines market accounted for US $ 1,751 Mn in 2020 and is expected to reach US $ 2,945 Mn by 2028 with a considerable CAGR of 6.8% during the forecast period of 2021 to 2028.

Poultry vaccines are primarily used to prevent and control infectious poultry diseases. Their application in poultry farming is intended to prevent or reduce the emergence of active disease at the farm level, thereby increasing output. Vaccines and vaccination programs vary significantly depending on several local factors such as farming type, disease trend, costs, and potential losses, and are generally managed by the poultry sector. In the last decade, the economic losses caused by major chronic diseases of poultry farms, such as avian influenza and Newcastle disease, have been massive for both the commercial and public sectors. However, vaccination should thus be used in the context of national or regional poultry disease eradication programs overseen by public veterinary services.

Drivers

Increasing incidences of poultry diseases

Increasing occurrence of zoonotic diseases

Rising consumption of poultry-derived products

Widened focus on food standards and safety

Restraints

Increasing cost of the vaccines

Increasing acceptance of vegan and vegetarian food

Opportunities

Increasing government involvement in poultry treatment

Leading industries expanding their vaccination programs

Report Coverage: 

The importance of vaccination in poultry farms

Vaccination plays a significant role in the management of the health of poultry farms. Vaccinations can help to prevent a variety of poultry diseases. Vaccination is a controlled process in which healthy birds are infected with a weakened or dead pathogen. Following vaccination, the bird's immune system reacts to the vaccine by stimulating an army of cells developed to find and destroy the invading pathogens before they cause harm to the bird. Following an attack, several specialized immune system cells known as memory cells remain. These neural connective cells will recall the infectious agent against which the bird has been immunized. Moreover, if the infectious agent is discovered later in life, the birds' immune system is capable of quick detection and destruction of the pathogens, resulting in disease protection and thus preserving the productive health of the flock.

Market Segmentation

Market By Disease

• Avian Influenza
• Infectious Bronchitis
• Newcastle Disease
• Marek's Disease
• Others

Avian influenza, also known as bird flu, is a disease associated with avian (bird) influenza (flu) Type A diseases. These viruses spread naturally among wild aquatic birds all over the world and can infect domestic and household poultry as well as other bird and animal species. Normally, bird flu viruses do not infect humans. Infection in humans with bird flu viruses has taken place on a sporadic basis. In recent days, avian influenza A (H7N9) has been reported in China, and it has also been detected in poultry. While mild illness has been observed in human cases, the majority of patients have suffered from severe respiratory illness, and some have died.

Market By Product

• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Recombinant Vaccines
• DNA Vaccines

Live attenuated vaccines are made from a living bacteria or virus that has been modified to weaken and decrease its virulence. A live attenuated vaccine elicits a strong immune response and, in many cases, provides lifelong immunity after only one or two doses. When compared with other vaccines, this has the ability to induce the immune system into producing a greater number of antibodies. Furthermore, immunization is more effective and protects against avian diseases such as infectious bursal disease, infectious bronchitis, and Newcastle disease. In addition, increasing R&D activities, especially in the field of vaccination, are boosting segment advancement by containing various outbreaks of the aforementioned diseases.

Market By Application

• Broiler
• Layer
• Breeder

Due to the rising use of vaccines at breeder farms to ensure the health of the poultry and increase farm productivity, the breeding stock application segment dominated the market in 2020. Breeder farms have increased in popularity as a result of proactive government initiatives, which have increased the number of poultry farmers and farms, breeders and integrators, and nutrient mills.

Market By End-User

• Veterinary Hospitals
• Poultry Firm
• Poultry Vaccination Center

Local chicken poultry farms are a valuable resource that helps impoverished people in developing nations to improve their lives. Household or domestic chicken production provides food and income and is an essential component of rural poor food security. However, widespread poultry diseases, overexploitation, and poor production practices are among the challenges to village poultry's productive output. As a result of these factors, demand for the poultry vaccination center segment is expected to rise in the forecasting period.

Poultry Vaccines Market Regional Overview

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Latin America

• Brazil
• Mexico
• Rest of Latin America

Asia-Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa